Direct oral anticoagulants: a practical guide for the emergency physician

Area of Science:

• Pharmacology
• Emergency Medicine
• Cardiology

Background:

• Direct oral anticoagulants (DOACs) are widely used for stroke prophylaxis in nonvalvular atrial fibrillation and venous thrombosis treatment.
• DOACs present advantages over warfarin, including efficacy, ease of use, and a favorable safety profile.
• Emergency departments (EDs) have developed expertise in managing DOAC-related bleeding but are slower in adopting DOAC prescription practices.

Purpose of the Study:

• To provide emergency clinicians with a practical guide for prescribing DOACs.
• To highlight red flags for identifying patients on DOACs at high risk of bleeding in the ED.
• To review current advances in managing DOAC-induced bleeding complications.

Main Methods:

• Review of current literature and clinical guidelines on DOACs.
• Discussion of practical considerations for DOAC prescription in emergency settings.
• Identification of key risk factors and management strategies for DOAC-related bleeding.

Main Results:

• DOACs are effective and safe alternatives to warfarin for specific indications.
• Emergency clinicians can play a crucial role in identifying high-risk patients and preventing bleeding.
• Established protocols exist for managing DOAC bleeding, with ongoing advancements.

Conclusions:

• Emergency clinicians are well-positioned to optimize DOAC prescribing and patient safety.
• Early identification of bleeding risks and prompt management are essential for DOAC therapy.
• This guide aims to enhance emergency department preparedness for DOAC management.